Selinexor-based treatments are associated with increased expression of T-cell activation markers in multiple myeloma
Abstract: Many currently approved therapies for multiple myeloma (MM) use the endogenous immune system. The indirect effects of cytotoxic antimyeloma agents on the immune microenvironment can impact on the success of subsequent or combined immune-directed therapies. In this study, we investigated th...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2025-12-01
|
| Colección: | Blood Immunology & Cellular Therapy |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S3050597625000090 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|